| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |